AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million

Biopharma

Home » Health and medicine » Biopharma

Precigen Announces Dosing of First Patients with UltraCAR-T® Cells Manufactured Using Proprietary UltraPorator™ System in Ongoing PRGN-3005 and PRGN-3006 Phase 1 Clinical Trials

– First patients dosed with UltraPorator manufactured PRGN-3005 UltraCAR-T cells at University of Washington/Fred Hutchinson Cancer Research Center and PRGN-3006 UltraCAR-T cells at Moffitt Cancer Center –...

Can We Recreate Every Human Cell Type In The Body? This UK Startup Thinks So.

Locus Biosciences signs contract with CARB-X to advance $14 million precision medicine program to develop crPhage™ product targeting Klebsiella pneumoniae infections

MORRISVILLE, N.C., Nov. 10, 2020 /PRNewswire/ –Locus Biosciences, a clinical-stage biopharmaceutical company, announced today that it has signed a contract with the global non-profit, Combating Antibiotic...

Ambrx Closes $200 million in Crossover Financing with Leading Healthcare Investors to Advance its Clinical and Preclinical Pipeline of Precision Biologics

eGenesis Announces Research Collaboration with Leading Academic Medical Center

U.K. Startup Just Closed $21 Million Series B To Engineer Cancer Attacking Microbes

LabGenius has closed an oversubscribed $15M extension round

GentiBio Expands Leadership Team and Partnership with MIGAL to Help Advance Development of Engineered Regulatory T Cell Therapies

Prokarium Closes $21M Series B Financing Round and Strengthens Board

Leaps by Bayer Leads USD 17 Million Series B Financing in Biotech Company Azitra

Absci

AbSci CEO Sean McClain Named as an Entrepreneur Of The Year® 2020 Pacific Northwest Region Award Winner

Jennifer Doudna

Jennifer Doudna’s New Gene Editing Company Launches With A $20 Million Round To Develop Genetic Medicines

Atomwise Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosis

Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant – Enabling Vaccines For All With No Sharks Killed

LogicBio Therapeutics Announces Proposed Public Offering of Common Stock